Combining Multiple Markers to Improve the Longitudinal Rate of Progression: Application to Clinical Trials on the Early Stage of Alzheimer's Disease

Statistics in Biopharmaceutical Research - United Kingdom
doi 10.1080/19466315.2012.756662